Collegium Pharmaceutical Inc
NASDAQ:COLL
Collegium Pharmaceutical Inc
NASDAQ:COLL
Price:
33.25
USD
0.06%
Market Closed
Market Cap:
$1.1B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Collegium Pharmaceutical Inc
NASDAQ:COLL
|
US |
|
B
|
Boustead Heavy Industries Corporation Bhd
KLSE:BHIC
|
MY |
|
K
|
Keck Seng (Malaysia) Bhd
KLSE:KSENG
|
MY |
|
M
|
MGX Minerals Inc
CNSX:XMG
|
CA |
|
U
|
Uzin Utz SE
SWB:UZU
|
DE |
|
E
|
Empresas CMPC SA
SGO:CMPC
|
CL |
|
Hainan Yedao Group Co Ltd
SSE:600238
|
CN |
|
P
|
Perenti Ltd
XMUN:FWG
|
AU |
|
PubMatic Inc
NASDAQ:PUBM
|
US |
|
Hunan Sokan New Materials Co Ltd
SSE:688157
|
CN |
|
T
|
Tion Renewables AG
XETRA:TION
|
DE |
|
Usha Martin Education And Solutions Ltd
NSE:UMESLTD
|
IN |
|
JW (Cayman) Therapeutics Co Ltd
HKEX:2126
|
CN |
|
A
|
Arabian Drilling Co
SAU:2381
|
SA |
|
Thungela Resources Ltd
LSE:TGA
|
ZA |
|
Banco Santander SA
MIL:1SANX
|
ES |
|
S
|
SoftBank Corp
SWB:3AG1
|
JP |
Balance Sheet
Balance Sheet Decomposition
Collegium Pharmaceutical Inc
Collegium Pharmaceutical Inc
Balance Sheet Decomposition is not available for
Collegium Pharmaceutical Inc
Collegium Pharmaceutical Inc
Balance Sheet
Collegium Pharmaceutical Inc
Collegium Pharmaceutical Inc
Currency: USD
| Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||
| Cash & Cash Equivalents |
8
|
2
|
96
|
153
|
119
|
147
|
170
|
174
|
186
|
174
|
239
|
71
|
231
|
|
| Cash Equivalents |
8
|
2
|
96
|
153
|
119
|
147
|
170
|
174
|
186
|
174
|
239
|
71
|
231
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
72
|
92
|
155
|
|
| Total Receivables |
0
|
0
|
0
|
2
|
10
|
78
|
73
|
83
|
106
|
183
|
180
|
229
|
211
|
|
| Accounts Receivables |
0
|
0
|
0
|
2
|
10
|
78
|
73
|
83
|
106
|
183
|
180
|
229
|
211
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
0
|
0
|
0
|
1
|
2
|
8
|
10
|
16
|
17
|
47
|
32
|
36
|
41
|
|
| Other Current Assets |
1
|
3
|
1
|
2
|
3
|
5
|
3
|
5
|
6
|
17
|
15
|
55
|
52
|
|
| Total Current Assets |
8
|
5
|
97
|
159
|
134
|
238
|
256
|
278
|
316
|
420
|
538
|
482
|
691
|
|
| PP&E Net |
1
|
1
|
1
|
1
|
2
|
9
|
21
|
27
|
27
|
26
|
22
|
20
|
16
|
|
| PP&E Gross |
1
|
1
|
1
|
1
|
2
|
9
|
21
|
27
|
27
|
26
|
22
|
20
|
16
|
|
| Accumulated Depreciation |
1
|
1
|
1
|
1
|
2
|
2
|
2
|
3
|
5
|
6
|
10
|
14
|
17
|
|
| Intangible Assets |
0
|
0
|
0
|
2
|
0
|
44
|
30
|
336
|
269
|
568
|
422
|
891
|
670
|
|
| Goodwill |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
134
|
134
|
162
|
146
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
81
|
27
|
28
|
107
|
134
|
|
| Other Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
134
|
134
|
162
|
146
|
|
| Total Assets |
9
N/A
|
5
-43%
|
98
+1 816%
|
162
+66%
|
136
-16%
|
291
+115%
|
306
+5%
|
644
+110%
|
692
+8%
|
1 174
+70%
|
1 143
-3%
|
1 664
+46%
|
1 657
0%
|
|
| Liabilities | ||||||||||||||
| Accounts Payable |
1
|
2
|
4
|
9
|
6
|
12
|
6
|
10
|
4
|
4
|
9
|
4
|
11
|
|
| Accrued Liabilities |
1
|
2
|
2
|
9
|
24
|
175
|
192
|
180
|
224
|
263
|
259
|
397
|
376
|
|
| Short-Term Debt |
0
|
5
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
1
|
3
|
3
|
2
|
2
|
4
|
48
|
48
|
163
|
183
|
65
|
29
|
|
| Other Current Liabilities |
0
|
0
|
0
|
5
|
0
|
0
|
0
|
2
|
3
|
4
|
7
|
44
|
25
|
|
| Total Current Liabilities |
3
|
10
|
8
|
26
|
32
|
189
|
202
|
240
|
280
|
434
|
458
|
510
|
440
|
|
| Long-Term Debt |
1
|
7
|
4
|
2
|
0
|
10
|
8
|
210
|
202
|
539
|
484
|
788
|
780
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
1
|
9
|
9
|
8
|
7
|
6
|
137
|
135
|
|
| Total Liabilities |
4
N/A
|
17
+394%
|
13
-27%
|
27
+115%
|
32
+16%
|
200
+534%
|
219
+10%
|
458
+109%
|
489
+7%
|
979
+100%
|
948
-3%
|
1 435
+51%
|
1 355
-6%
|
|
| Equity | ||||||||||||||
| Common Stock |
74
|
77
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
81
|
102
|
129
|
223
|
298
|
337
|
360
|
333
|
256
|
281
|
233
|
164
|
101
|
|
| Additional Paid In Capital |
12
|
12
|
214
|
358
|
402
|
429
|
447
|
519
|
502
|
538
|
566
|
590
|
625
|
|
| Treasury Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
43
|
62
|
137
|
198
|
223
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
6
N/A
|
12
N/A
|
85
N/A
|
135
+59%
|
104
-23%
|
92
-12%
|
87
-5%
|
186
+113%
|
203
+9%
|
195
-4%
|
195
+0%
|
229
+17%
|
302
+32%
|
|
| Total Liabilities & Equity |
9
N/A
|
5
-43%
|
98
+1 816%
|
162
+66%
|
136
-16%
|
291
+115%
|
306
+5%
|
644
+110%
|
692
+8%
|
1 174
+70%
|
1 143
-3%
|
1 664
+46%
|
1 657
0%
|
|
| Shares Outstanding | ||||||||||||||
| Common Shares Outstanding |
20
|
20
|
21
|
29
|
33
|
33
|
34
|
35
|
34
|
34
|
32
|
31
|
32
|
|
Switch to:
Switch to:
See Also
Discover More
